← Leaderboards
June-Wha Rhee
Stanford University
$1,627,821
Attributed
$1,627,821
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $698K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,627,821 · 3
By mechanism
K08$760,408 · 1
R01$697,952 · 1
F32$169,461 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Joseph C Wu$80,370,369
- Eran Bendavid$2,249,834
- James A Spudich$18,041,927
- Lei Stanley Qi$14,888,989
- Masayuki Yazawa$6,289,286
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypePreventCardiovascular SystemCellsCalciumMolecularCell LineInduced Pluripotent Stem CellCardiacMuscle CellsTherapeutic TargetResearch PersonnelCardiac MyocytesPathogenesisSymptomsGenotypeMedicineAffectGenerationsTechnologyLeadClinicMolecular TargetMouse Model
Grant awards (10)
Novel mechanisms and therapeutics for Tyrosine Kinase Inhibitor-induced Cardiotoxicity$697,952
R01 · FY2025 · HL · contact PI
Patient-specific modeling of metabolic dysfunction in statin-induced myopathy using iPSC-derived myocytes$90,326
K08 · FY2024 · HL · contact PI
Patient-specific modeling of metabolic dysfunction in statin-induced myopathy using iPSC-derived myocytes$75,600
K08 · FY2024 · HL · contact PI
Patient-specific modeling of metabolic dysfunction in statin-induced myopathy using iPSC-derived myocytes$137,160
K08 · FY2023 · HL · contact PI
Patient-specific modeling of metabolic dysfunction in statin-induced myopathy using iPSC-derived myocytes$137,160
K08 · FY2022 · HL · contact PI
Patient-specific modeling of metabolic dysfunction in statin-induced myopathy using iPSC-derived myocytes$153,626
K08 · FY2021 · HL · contact PI
Patient-specific modeling of metabolic dysfunction in statin-induced myopathy using iPSC-derived myocytes$166,536
K08 · FY2020 · HL · contact PI
The use of human induced pluripotent stem cell-derived cardiomyocytes to describe the role of α-Tropomyosin mutations in hypertrophic cardiomyopathy$34,539
F32 · FY2019 · HL · contact PI
The use of human induced pluripotent stem cell-derived cardiomyocytes to describe the role of α-Tropomyosin mutations in hypertrophic cardiomyopathy$70,145
F32 · FY2018 · HL · contact PI
The use of human induced pluripotent stem cell-derived cardiomyocytes to describe the role of α-Tropomyosin mutations in hypertrophic cardiomyopathy$64,777
F32 · FY2016 · HL · contact PI